{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:39Z","timestamp":1792787919064,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China zhongguancun Precision Medicine science and technology foundation","award":["No.2024J2Y4367"],"award-info":[{"award-number":["No.2024J2Y4367"]}]},{"name":"China zhongguancun Precision Medicine science and technology foundation","award":["No.2024J2Y4367"],"award-info":[{"award-number":["No.2024J2Y4367"]}]},{"name":"China zhongguancun Precision Medicine science and technology foundation","award":["No.2024J2Y4367"],"award-info":[{"award-number":["No.2024J2Y4367"]}]},{"name":"China zhongguancun Precision Medicine science and technology foundation","award":["No.2024J2Y4367"],"award-info":[{"award-number":["No.2024J2Y4367"]}]},{"name":"China zhongguancun Precision Medicine science and technology foundation","award":["No.2024J2Y4367"],"award-info":[{"award-number":["No.2024J2Y4367"]}]},{"name":"China zhongguancun Precision Medicine science and technology foundation","award":["No.2024J2Y4367"],"award-info":[{"award-number":["No.2024J2Y4367"]}]},{"name":"China zhongguancun Precision Medicine science and technology foundation","award":["No.2024J2Y4367"],"award-info":[{"award-number":["No.2024J2Y4367"]}]},{"name":"China zhongguancun Precision Medicine science and technology foundation","award":["No.2024J2Y4367"],"award-info":[{"award-number":["No.2024J2Y4367"]}]},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["No.JZ2025064"],"award-info":[{"award-number":["No.JZ2025064"]}]},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["No.JZ2025064"],"award-info":[{"award-number":["No.JZ2025064"]}]},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["No.JZ2025064"],"award-info":[{"award-number":["No.JZ2025064"]}]},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["No.JZ2025064"],"award-info":[{"award-number":["No.JZ2025064"]}]},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["No.JZ2025064"],"award-info":[{"award-number":["No.JZ2025064"]}]},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["No.JZ2025064"],"award-info":[{"award-number":["No.JZ2025064"]}]},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["No.JZ2025064"],"award-info":[{"award-number":["No.JZ2025064"]}]},{"name":"Guangdong Yiyang Healthcare Charity Foundation","award":["No.JZ2025064"],"award-info":[{"award-number":["No.JZ2025064"]}]},{"name":"National Natural Science Foundation of China","award":["No. 82302640"],"award-info":[{"award-number":["No. 82302640"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["No. 82302640"],"award-info":[{"award-number":["No. 82302640"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["No. 82302640"],"award-info":[{"award-number":["No. 82302640"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["No. 82302640"],"award-info":[{"award-number":["No. 82302640"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["No. 82302640"],"award-info":[{"award-number":["No. 82302640"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["No. 82302640"],"award-info":[{"award-number":["No. 82302640"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["No. 82302640"],"award-info":[{"award-number":["No. 82302640"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of China","award":["No. 82302640"],"award-info":[{"award-number":["No. 82302640"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanghai Rehabilitation Medicine Association Health Management Special Fund Project","award":["No.2024JGYQ11"],"award-info":[{"award-number":["No.2024JGYQ11"]}]},{"name":"Shanghai Rehabilitation Medicine Association Health Management Special Fund Project","award":["No.2024JGYQ11"],"award-info":[{"award-number":["No.2024JGYQ11"]}]},{"name":"Shanghai Rehabilitation Medicine Association Health Management Special Fund Project","award":["No.2024JGYQ11"],"award-info":[{"award-number":["No.2024JGYQ11"]}]},{"name":"Shanghai Rehabilitation Medicine Association Health Management Special Fund Project","award":["No.2024JGYQ11"],"award-info":[{"award-number":["No.2024JGYQ11"]}]},{"name":"Shanghai Rehabilitation Medicine Association Health Management Special Fund Project","award":["No.2024JGYQ11"],"award-info":[{"award-number":["No.2024JGYQ11"]}]},{"name":"Shanghai Rehabilitation Medicine Association Health Management Special Fund Project","award":["No.2024JGYQ11"],"award-info":[{"award-number":["No.2024JGYQ11"]}]},{"name":"Shanghai Rehabilitation Medicine Association Health Management Special Fund Project","award":["No.2024JGYQ11"],"award-info":[{"award-number":["No.2024JGYQ11"]}]},{"name":"Shanghai Rehabilitation Medicine Association Health Management Special Fund Project","award":["No.2024JGYQ11"],"award-info":[{"award-number":["No.2024JGYQ11"]}]},{"name":"Guangdong Medical Scientific Research","award":["No. A2024619"],"award-info":[{"award-number":["No. A2024619"]}]},{"name":"Guangdong Medical Scientific Research","award":["No. A2024619"],"award-info":[{"award-number":["No. A2024619"]}]},{"name":"Guangdong Medical Scientific Research","award":["No. A2024619"],"award-info":[{"award-number":["No. A2024619"]}]},{"name":"Guangdong Medical Scientific Research","award":["No. A2024619"],"award-info":[{"award-number":["No. A2024619"]}]},{"name":"Guangdong Medical Scientific Research","award":["No. A2024619"],"award-info":[{"award-number":["No. A2024619"]}]},{"name":"Guangdong Medical Scientific Research","award":["No. A2024619"],"award-info":[{"award-number":["No. A2024619"]}]},{"name":"Guangdong Medical Scientific Research","award":["No. A2024619"],"award-info":[{"award-number":["No. A2024619"]}]},{"name":"Guangdong Medical Scientific Research","award":["No. A2024619"],"award-info":[{"award-number":["No. A2024619"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04400-5","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:33:42Z","timestamp":1783413222000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ANGPTL4 contributes to osimertinib resistance through NDRG1-associated extracellular matrix remodeling in EGFR-mutant NSCLC organoid models"],"prefix":"10.1186","volume":"26","author":[{"given":"Dai-Yan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Di","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"4400_CR1","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang T, Guo L, Ren T, Yang Y. Stromal extracellular matrix is a microenvironmental cue promoting resistance to EGFR tyrosine kinase inhibitors in lung cancer cells. Int J Biochem Cell Biol 2018:96\u2013106.","DOI":"10.1016\/j.biocel.2018.11.001"},{"issue":"4","key":"4400_CR2","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jtho.2016.12.014","volume":"12","author":"E Castellanos","year":"2016","unstructured":"Castellanos E, Feld E, Horn L. Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non-Small Cell Lung Cancer. J Thorac Oncol. 2016;12(4):612\u201323.","journal-title":"J Thorac Oncol"},{"issue":"2","key":"4400_CR3","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtho.2020.10.006","volume":"16","author":"X Le","year":"2020","unstructured":"Le X, Nilsson M, Goldman J, Reck M, Nakagawa K, Kato T, Ares LP, Frimodt-Moller B, Wolff K, Visseren-Grul C, et al. Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC. J Thorac Oncol. 2020;16(2):205\u201315.","journal-title":"J Thorac Oncol"},{"issue":"8","key":"4400_CR4","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345\u201356.","journal-title":"Nat Med"},{"issue":"6","key":"4400_CR5","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s40259-022-00556-4","volume":"36","author":"D Brazel","year":"2022","unstructured":"Brazel D, Kroening G, Nagasaka M. Non-small Cell Lung Cancer with EGFR or HER2 Exon 20 Insertion Mutations: Diagnosis and Treatment Options. BioDrugs. 2022;36(6):717\u201329.","journal-title":"BioDrugs"},{"issue":"11","key":"4400_CR6","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1158\/1535-7163.MCT-20-0229","volume":"19","author":"K Kashima","year":"2020","unstructured":"Kashima K, Kawauchi H, Tanimura H, Tachibana Y, Chiba T, Torizawa T, Sakamoto H. CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19\/T790M\/C797S Mutation. Mol Cancer Ther. 2020;19(11):2288\u201397.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"4400_CR7","doi-asserted-by":"publisher","first-page":"2481392","DOI":"10.1080\/14756366.2025.2481392","volume":"40","author":"D Zhang","year":"2025","unstructured":"Zhang D, Zhao J, Yang Y, Dai Q, Zhang N, Mi Z, Hu Q, Liu X. Fourth-generation EGFR-TKI to overcome C797S mutation: past, present, and future. J Enzyme Inhib Med Chem. 2025;40(1):2481392.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"9","key":"4400_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41416-019-0573-8","volume":"121","author":"A Leonetti","year":"2019","unstructured":"Leonetti A, Sharma S, Minari R, Perego P, Giovannetti E, Tiseo M. Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer. Br J Cancer. 2019;121(9):725\u201337.","journal-title":"Br J Cancer"},{"issue":"1","key":"4400_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-018-0793-1","volume":"17","author":"Q Liu","year":"2018","unstructured":"Liu Q, Yu S, Zhao W, Qin S, Chu Q, Wu K. EGFR-TKIs resistance via EGFR-independent signaling pathways. Mol Cancer. 2018;17(1):53.","journal-title":"Mol Cancer"},{"key":"4400_CR10","doi-asserted-by":"publisher","first-page":"102557","DOI":"10.1016\/j.ctrv.2023.102557","volume":"116","author":"Z Zalaquett","year":"2023","unstructured":"Zalaquett Z, Catherine Rita Hachem M, Kassis Y, Hachem S, Eid R, Raphael Kourie H, Planchard D. Acquired resistance mechanisms to osimertinib: The constant battle. Cancer Treat Rev. 2023;116:102557.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"4400_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13045-022-01391-4","volume":"15","author":"K Fu","year":"2022","unstructured":"Fu K, Xie F, Wang F, Fu L. Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance. J Hematol Oncol. 2022;15(1):173.","journal-title":"J Hematol Oncol"},{"issue":"11","key":"4400_CR12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1161\/01.RES.0000250758.63358.91","volume":"99","author":"A Cazes","year":"2006","unstructured":"Cazes A, Galaup A, Chomel C, Bignon M, Br\u00e9chot N, Le Jan S, Weber H, Corvol P, Muller L, Germain S, et al. Extracellular matrix-bound angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res. 2006;99(11):1207\u201315.","journal-title":"Circ Res"},{"issue":"8","key":"4400_CR13","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.molmed.2019.05.010","volume":"25","author":"B Aryal","year":"2019","unstructured":"Aryal B, Price NL, Suarez Y, Fern\u00e1ndez-Hernando C. ANGPTL4 in Metabolic and Cardiovascular Disease. Trends Mol Med. 2019;25(8):723\u201334.","journal-title":"Trends Mol Med"},{"issue":"8","key":"4400_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.5483\/BMBRep.2024-0082","volume":"57","author":"MS Park","year":"2024","unstructured":"Park MS, Kim SE, Lee P, Lee J-H, Jung KH, Hong S-S. Potential role of ANGPTL4 in cancer progression, metastasis, and metabolism: a brief review. BMB Rep. 2024;57(8):343\u201351.","journal-title":"BMB Rep"},{"key":"4400_CR15","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jare.2024.12.003","volume":"75","author":"Z Xiong","year":"2024","unstructured":"Xiong Z, Zhuang R-L, Yu S-L, Xie Z-X, Peng S-R, Li Z-A, Li B-H, Xie J-J, Li Y-N, Li K-W, et al. Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer. J Adv Res. 2024;75:663\u201378.","journal-title":"J Adv Res"},{"issue":"3","key":"4400_CR16","doi-asserted-by":"publisher","first-page":"927","DOI":"10.3892\/or.2020.7647","volume":"44","author":"S Zhou","year":"2020","unstructured":"Zhou S, Wang R, Xiao H. Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4. Oncol Rep. 2020;44(3):927\u201338.","journal-title":"Oncol Rep"},{"key":"4400_CR17","doi-asserted-by":"crossref","unstructured":"Li C, Wang Q, Luo Y, Xiang J. TAZ Regulates the Cisplatin Resistance of Epithelial Ovarian Cancer Cells via the ANGPTL4\/SOX2 Axis. Anal Cell Pathol (Amst) 2022, 2022:5632164.","DOI":"10.1155\/2022\/5632164"},{"issue":"78","key":"4400_CR18","doi-asserted-by":"publisher","first-page":"eabq6691","DOI":"10.1126\/sciimmunol.abq6691","volume":"7","author":"ID Odell","year":"2022","unstructured":"Odell ID, Steach H, Gauld SB, Reinke-Breen L, Karman J, Carr TL, Wetter JB, Phillips L, Hinchcliff M, Flavell RA. Epiregulin is a dendritic cell-derived EGFR ligand that maintains skin and lung fibrosis. Sci Immunol. 2022;7(78):eabq6691.","journal-title":"Sci Immunol"},{"issue":"1","key":"4400_CR19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13045-022-01278-4","volume":"15","author":"H Xu","year":"2022","unstructured":"Xu H, Jiao D, Liu A, Wu K. Tumor organoids: applications in cancer modeling and potentials in precision medicine. J Hematol Oncol. 2022;15(1):58.","journal-title":"J Hematol Oncol"},{"key":"4400_CR20","doi-asserted-by":"crossref","unstructured":"Lee SH, Hu W, Matulay JT, Silva MV, Owczarek TB, Kim K, Chua CW, Barlow LJ, Kandoth C, Williams AB et al. Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer. Cell 2018, 173(2):515\u2013528.e17.","DOI":"10.1016\/j.cell.2018.03.017"},{"key":"4400_CR21","doi-asserted-by":"crossref","unstructured":"Choi Y-M, Lee H, Ann M, Song M, Rheey J, Jang J. 3D bioprinted vascularized lung cancer organoid models with underlying disease capable of more precise drug evaluation. Biofabrication 2023, 15(3):1758\u20135090","DOI":"10.1088\/1758-5090\/acd95f"},{"key":"4400_CR22","doi-asserted-by":"publisher","first-page":"1573686","DOI":"10.3389\/fimmu.2025.1573686","volume":"16","author":"L Zhang","year":"2025","unstructured":"Zhang L, Zhao J, Su C, Wu J, Jiang L, Chi H, Wang Q. Organoid models of ovarian cancer: resolving immune mechanisms of metabolic reprogramming and drug resistance. Front Immunol. 2025;16:1573686.","journal-title":"Front Immunol"},{"issue":"6","key":"4400_CR23","first-page":"1155","volume":"45","author":"G Chen","year":"2022","unstructured":"Chen G, Gong T, Wang Z, Wang Z, Lin X, Chen S, Sun C, Zhao W, Kong Y, Ai H, et al. Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution. Cell Oncol (Dordr). 2022;45(6):1155\u201367.","journal-title":"Cell Oncol (Dordr)"},{"issue":"5","key":"4400_CR24","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1158\/1078-0432.CCR-19-1376","volume":"26","author":"R Shi","year":"2019","unstructured":"Shi R, Radulovich N, Ng C, Liu N, Notsuda H, Cabanero M, Martins-Filho SN, Raghavan V, Li Q, Mer AS, et al. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer. Clin Cancer Res. 2019;26(5):1162\u201374.","journal-title":"Clin Cancer Res"},{"key":"4400_CR25","doi-asserted-by":"crossref","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform 2021;22(6):bbab2","DOI":"10.1093\/bib\/bbab260"},{"issue":"1A","key":"4400_CR26","first-page":"A68","volume":"19","author":"K Tomczak","year":"2015","unstructured":"Tomczak K, Czerwi\u0144ska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Pozn). 2015;19(1A):A68\u201377.","journal-title":"Contemp Oncol (Pozn)"},{"issue":"1","key":"4400_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41597-023-02074-6","volume":"10","author":"KH Prazanowska","year":"2023","unstructured":"Prazanowska KH, Lim SB. An integrated single-cell transcriptomic dataset for non-small cell lung cancer. Sci Data. 2023;10(1):167.","journal-title":"Sci Data"},{"issue":"6","key":"4400_CR28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s43018-024-00756-7","volume":"5","author":"S Sinha","year":"2024","unstructured":"Sinha S, Vegesna R, Mukherjee S, Kammula AV, Dhruba SR, Wu W, Kerr DL, Nair NU, Jones MG, Yosef N, et al. PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors. Nat Cancer. 2024;5(6):938\u201352.","journal-title":"Nat Cancer"},{"issue":"7","key":"4400_CR29","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van de Sande","year":"2020","unstructured":"Van de Sande B, Flerin C, Davie K, De Waegeneer M, Hulselmans G, Aibar S, Seurinck R, Saelens W, Cannoodt R, Rouchon Q, et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protoc. 2020;15(7):2247\u201376.","journal-title":"Nat Protoc"},{"issue":"3","key":"4400_CR30","doi-asserted-by":"publisher","first-page":"100434","DOI":"10.1016\/j.patter.2022.100434","volume":"3","author":"D Osorio","year":"2022","unstructured":"Osorio D, Zhong Y, Li G, Xu Q, Yang Y, Tian Y, Chapkin RS, Huang JZ, Cai JJ. scTenifoldKnk: An efficient virtual knockout tool for gene function predictions via single-cell gene regulatory network perturbation. Patterns (N Y). 2022;3(3):100434.","journal-title":"Patterns (N Y)"},{"key":"4400_CR31","doi-asserted-by":"publisher","first-page":"154626","DOI":"10.1016\/j.phymed.2022.154626","volume":"110","author":"C Chen","year":"2022","unstructured":"Chen C, Chen J, Wang Y, Fang L, Guo C, Sang T, Peng H, Zhao Q, Chen S, Lin X, et al. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-\u03b2\/Smad signaling. Phytomedicine. 2022;110:154626.","journal-title":"Phytomedicine"},{"key":"4400_CR32","doi-asserted-by":"publisher","first-page":"36402","DOI":"10.1038\/srep36402","volume":"7","author":"BS Shah","year":"2017","unstructured":"Shah BS, Chen M, Suzuki T, Embree M, Kong K, Lee CH, He L, Xiang L, Ahn JA, Ding S, et al. Pyrintegrin Induces Soft Tissue Formation by Transplanted or Endogenous Cells. Sci Rep. 2017;7:36402.","journal-title":"Sci Rep"},{"key":"4400_CR33","doi-asserted-by":"crossref","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010, 10(1):1038\/nrc2748","DOI":"10.1038\/nrc2748"},{"issue":"1","key":"4400_CR34","doi-asserted-by":"publisher","first-page":"e2310685120","DOI":"10.1073\/pnas.2310685120","volume":"121","author":"H Hu","year":"2023","unstructured":"Hu H, Luo S, Lai P, Lai M, Mao L, Zhang S, Jiang Y, Wen J, Zhou W, Liu X, et al. ANGPTL4 binds to the leptin receptor to regulate ectopic bone formation. Proc Natl Acad Sci U S A. 2023;121(1):e2310685120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4400_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12885-025-13954-y","volume":"25","author":"L Li","year":"2025","unstructured":"Li L, Wu T, Gong G, Li B, Feng J, Xu L, Zhao H, Gao X. NDRG1 alleviates Erastin-induced ferroptosis of hepatocellular carcinoma. BMC Cancer. 2025;25(1):522.","journal-title":"BMC Cancer"},{"issue":"12","key":"4400_CR36","doi-asserted-by":"publisher","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","volume":"60","author":"JJ Irwin","year":"2020","unstructured":"Irwin JJ, Tang KG, Young J, Dandarchuluun C, Wong BR, Khurelbaatar M, Moroz YS, Mayfield J, Sayle RA. ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery. J Chem Inf Model. 2020;60(12):6065\u201373.","journal-title":"J Chem Inf Model"},{"issue":"2","key":"4400_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455\u201361.","journal-title":"J Comput Chem"},{"issue":"10","key":"4400_CR38","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/jcc.21787","volume":"32","author":"N Michaud-Agrawal","year":"2011","unstructured":"Michaud-Agrawal N, Denning EJ, Woolf TB, Beckstein O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J Comput Chem. 2011;32(10):2319\u201327.","journal-title":"J Comput Chem"},{"issue":"5","key":"4400_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","volume":"10","author":"S Genheden","year":"2015","unstructured":"Genheden S, Ryde U. The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10(5):449\u201361.","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"4400_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00109-020-01990-z","volume":"99","author":"K Kretzschmar","year":"2020","unstructured":"Kretzschmar K. Cancer research using organoid technology. J Mol Med (Berl). 2020;99(4):501\u201315.","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"4400_CR41","first-page":"903","volume":"22","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Li Y, Jing X, Weng L, Liu X, Liu Q, Chen K. Organoid models in oncology: advancing precision cancer therapy and vaccine development. Cancer Biol Med. 2025;22(8):903\u201327.","journal-title":"Cancer Biol Med"},{"issue":"8","key":"4400_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","volume":"24","author":"R Polak","year":"2024","unstructured":"Polak R, Zhang ET, Kuo CJ. Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment. Nat Rev Cancer. 2024;24(8):523\u201339.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"4400_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MOH.0000000000000580","volume":"27","author":"C Fern\u00e1ndez-Hernando","year":"2020","unstructured":"Fern\u00e1ndez-Hernando C, Su\u00e1rez Y. ANGPTL4: a multifunctional protein involved in metabolism and vascular homeostasis. Curr Opin Hematol. 2020;27(3):206\u201313.","journal-title":"Curr Opin Hematol"},{"key":"4400_CR44","doi-asserted-by":"crossref","unstructured":"Saponaro C, Gammaldi N, Cavallo V, Ram\u00edrez-Morales MA, Zito FA, Sonnessa M, Vari F, Serra I, De Summa S, Giudetti AM et al. Insight into the Regulation of NDRG1 Expression. Int J Mol Sci 2025, 26(8):3582","DOI":"10.3390\/ijms26083582"},{"issue":"1","key":"4400_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-019-0965-7","volume":"18","author":"S Maacha","year":"2019","unstructured":"Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S, Grivel J-C. Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol Cancer. 2019;18(1):55.","journal-title":"Mol Cancer"},{"issue":"2","key":"4400_CR46","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41556-022-00843-w","volume":"24","author":"P Romani","year":"2022","unstructured":"Romani P, Nirchio N, Arboit M, Barbieri V, Tosi A, Michielin F, Shibuya S, Benoist T, Wu D, Hindmarch CCT, et al. Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance. Nat Cell Biol. 2022;24(2):168\u201380.","journal-title":"Nat Cell Biol"},{"issue":"7","key":"4400_CR47","first-page":"571","volume":"21","author":"J Mou","year":"2024","unstructured":"Mou J, Li C, Zheng Q, Meng X, Tang H. Research progress in tumor angiogenesis and drug resistance in breast cancer. Cancer Biol Med. 2024;21(7):571\u201385.","journal-title":"Cancer Biol Med"},{"issue":"3","key":"4400_CR48","first-page":"773","volume":"2","author":"RL Flaherty","year":"2019","unstructured":"Flaherty RL, Falcinelli M, Flint MS. Stress and drug resistance in cancer. Cancer Drug Resist. 2019;2(3):773\u201386.","journal-title":"Cancer Drug Resist"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04400-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04400-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:49:24Z","timestamp":1791154164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04400-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4400"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04400-5","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Guangdong Second People's Hospital and performed under the ethical guidelines of the Helsinki Declaration (2025-KY-SQ-227). All participants provided written informed consent prior to their enrollment in the study.","order":1,"name":"Ethics","label":"Institutional review board statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"331"}}